Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)

Peer Review reports

Original Submission
20 Feb 2024	Submitted	Original manuscript
26 Mar 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
8 Apr 2024	Reviewed	Reviewer Report
3 May 2024	Reviewed	Reviewer Report
26 May 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
Resubmission - Version 2
26 Mar 2024	Submitted	Manuscript version 2
29 May 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
Resubmission - Version 3
29 May 2024	Submitted	Manuscript version 3
30 May 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
Resubmission - Version 4
30 May 2024	Submitted	Manuscript version 4
10 Jun 2024	Reviewed	Reviewer Report - Peter J. Kitonsa
3 Jul 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
Resubmission - Version 5
3 Jul 2024	Submitted	Manuscript version 5
8 Jul 2024	Author responded	Author comments - Alberto L Garcia-Basteiro
Resubmission - Version 6
8 Jul 2024	Submitted	Manuscript version 6
Publishing
23 Jul 2024	Editorially accepted
15 Aug 2024	Article published	10.1186/s12879-024-09651-z

Back to article page